Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 238 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implantable Cardioverter Defibrillator Clear all

Conditions: Sudden Cardiac Arrest
Interventions: Defibrillation; Device
Lead sponsor: Kestra Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 5,179 participants
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cardiomyopathy, Dilated, Arrhythmia, Anger, Stress
Interventions: Cognitive Behavioral Stress Management (CBSM), Patient Education; Behavioral · Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years to 85 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Congestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial Fibrillation
Interventions: Cardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 30
States / cities: Anchorage, Alaska • Phoenix, Arizona • Santa Monica, California + 27 more

Conditions: Atrial Fibrillation, Arrythmia
Interventions: Impulse Dynamics Optimizer Device; Device
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Cardiac Arrest, Sudden
Interventions: ASSURE™ Wearable Cardioverter Defibrillator (WCD); Device
Lead sponsor: Kestra Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 10
States / cities: Anchorage, Alaska • Hammond, Louisiana • Takoma Park, Maryland + 7 more

Conditions: Ischemic Cardiomyopathy, Hibernating Myocardium, Nerve; Disorder, Sympathetic
Interventions: Positron Emission Tomography; Radiation
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 257 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Tachycardia, Congestive Heart Failure
Interventions: Cardiac resynchronization therapy with defibrillation, Implantable Cardioverter Defibrillator (ICD); Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 1,820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Arrhythmia
Interventions: Intervention; Behavioral
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Aurora, Colorado • Lone Tree, Colorado • Greenville, North Carolina

Conditions: Defibrillator, Tricuspid Valve Regurgitation
Interventions: Defibrillator; Device
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pacemaker DDD, Implantable Defibrillator User
Interventions: Alert-based care, Guideline-based care; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: MRI
Interventions: MRI; Diagnostic Test
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 9 Years to 99 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2030
U.S. locations: 2
States / cities: Portland, Oregon

Conditions: Ventricular Arrhythmia, Ventricular Tachycardia, Premature Ventricular Contraction (PVC), Cardiomyopathy
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 34
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 25 more

Conditions: Arrhythmias, Cardiac, Heart Diseases, Cardiovascular Diseases, Implantable Cardioverter Defibrillator
Interventions: Azimilide Dihydrochloride, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 83
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 72 more

Conditions: Foramen Ovale, Patent
Interventions: Aspirin, Cardiovascular Implantable Device (CIED), Gore Cardioform Septal Occluder; Drug · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Coronary Artery Disease, Hypertension, Dyslipidemia, Diabetes
Interventions: magnesium L-lactate; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Sudden Cardiac Arrest
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 19 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Burlington, North Carolina • Durham, North Carolina

Conditions: Sarcopenia
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Tachycardia, Ventricular, Implantable Cardioverter Defibrillator (ICD), Fibrillation, Ventricular, Syncope
Interventions: Implanted Device; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 31
States / cities: Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 28 more

Conditions: Cardiomyopathy
Interventions: Nominal T shock setting, Educated T shock setting; Device
Lead sponsor: James Merrill; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Kingsport, Tennessee

Conditions: Atrial Fibrillation, Atrial Flutter, Stroke, Embolism, Systemic Arterial, Major Bleeding
Interventions: Home Monitoring Guided OAC, Physician-Directed OAC; Drug
Lead sponsor: Biotronik, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,718 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 73
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 70 more

Conditions: Heart Failure, Congestive
Interventions: Cardiac Resynchronization Therapy Device; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 1,024 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 93
States / cities: Huntsville, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 90 more

Conditions: Congestive Heart Failure, Cardiac Resynchronization Therapy
Interventions: Vipassana Meditation practice and instruction, Standard Medical Care; Behavioral · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 85 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Implantable Defibrillator User, Terminal Illness
Interventions: GAME-EOL; Behavioral
Lead sponsor: Debra Moser; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Sick Sinus Syndrome, AV Block, Heart Failure
Interventions: Device data collection; Procedure
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Huntsville, Alabama • Sayre, Pennsylvania • Greenville, South Carolina

Search by objective public record fields.

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Mental Stress Reduction in Defibrillator Patients

Clinical Investigation of the Medtronic Concerto™ Device

Arrythmia Burden in Cardiac Contractility Modulation (CCM)

ASSURE WCD Clinical Evaluation - Detection and Safety Study

Prediction of ARrhythmic Events With Positron Emission Tomography

MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy

Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education

Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices

VAPORHCS/OHSU J: MRI and Devices

IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)

Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

PREPARE - Primary Prevention Parameters Evaluation

Comparison of VF Induction Techniques During Medtronic ICD Implant (VF) (ICD)

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure

Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation

GAMification to Encourage End-Of-Life Discussions Between ICD Patients and Caregivers

HBP Device EGM Data Collection